Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	galactoside binding	LGALS9B LGALS9 GLB1	1.61e-05	9	117	3	GO:0016936
GeneOntologyMolecularFunction	lipid transporter activity	ATP8B3 SLCO3A1 ATP10B APOB SLC22A8 ABCA6 ABCA5 SLCO2A1	2.04e-05	196	117	8	GO:0005319
GeneOntologyMolecularFunction	prostaglandin transmembrane transporter activity	SLCO3A1 SLC22A8 SLCO2A1	6.81e-05	14	117	3	GO:0015132
GeneOntologyMolecularFunction	icosanoid transmembrane transporter activity	SLCO3A1 SLC22A8 SLCO2A1	8.47e-05	15	117	3	GO:0071714
GeneOntologyBiologicalProcess	regulation of T-helper 17 type immune response	LGALS9B TBX21 LGALS9 NLRP10 BRD2	7.42e-06	47	119	5	GO:2000316
GeneOntologyBiologicalProcess	T-helper 17 type immune response	LGALS9B TBX21 LGALS9 NLRP10 BRD2	3.41e-05	64	119	5	GO:0072538
MousePheno	maxillary sinus inflammation	KIF27 NME5 ULK4	3.55e-07	3	100	3	MP:0030113
Domain	Cell_morpho_N	FRYL FRY	3.96e-05	2	118	2	IPR025614
Domain	DUF3512	BRD7 BRD9	3.96e-05	2	118	2	IPR021900
Domain	Cell_Morphogen_C	FRYL FRY	3.96e-05	2	118	2	IPR025481
Domain	MOR2-PAG1_mid	FRYL FRY	3.96e-05	2	118	2	IPR029473
Domain	MOR2-PAG1_mid	FRYL FRY	3.96e-05	2	118	2	PF14228
Domain	MOR2-PAG1_C	FRYL FRY	3.96e-05	2	118	2	PF14225
Domain	MOR2-PAG1_N	FRYL FRY	3.96e-05	2	118	2	PF14222
Domain	DUF3512	BRD7 BRD9	3.96e-05	2	118	2	PF12024
Domain	BROMODOMAIN_1	ASH1L BRD2 BRD7 BRD9	8.51e-05	37	118	4	PS00633
Domain	Bromodomain	ASH1L BRD2 BRD7 BRD9	9.47e-05	38	118	4	PF00439
Domain	BROMODOMAIN_2	ASH1L BRD2 BRD7 BRD9	1.28e-04	41	118	4	PS50014
Domain	Bromodomain	ASH1L BRD2 BRD7 BRD9	1.41e-04	42	118	4	IPR001487
Domain	BROMO	ASH1L BRD2 BRD7 BRD9	1.41e-04	42	118	4	SM00297
Domain	-	ASH1L BRD2 BRD7 BRD9	1.41e-04	42	118	4	1.20.920.10
Domain	-	HEXA SLC3A2 GLB1	1.39e-03	35	118	3	3.20.20.80
Domain	Hydrolase_3	ATP8B3 ATP10B	1.72e-03	10	118	2	PF08282
Domain	Glyco_hydro_catalytic_dom	HEXA SLC3A2 GLB1	1.77e-03	38	118	3	IPR013781
Domain	MACPF	BRINP1 ASTN2	2.10e-03	11	118	2	PF01823
Domain	ABC_A	ABCA6 ABCA5	2.51e-03	12	118	2	IPR026082
Domain	OA_transporter	SLCO3A1 SLCO2A1	2.51e-03	12	118	2	IPR004156
Domain	MACPF	BRINP1 ASTN2	2.51e-03	12	118	2	IPR020864
Domain	MACPF	BRINP1 ASTN2	2.51e-03	12	118	2	SM00457
Domain	OATP	SLCO3A1 SLCO2A1	2.51e-03	12	118	2	PF03137
Domain	P_typ_ATPase_c	ATP8B3 ATP10B	3.43e-03	14	118	2	IPR032630
Domain	P-type_ATPase_N	ATP8B3 ATP10B	3.43e-03	14	118	2	IPR032631
Domain	P-type_ATPase_IV	ATP8B3 ATP10B	3.43e-03	14	118	2	IPR006539
Domain	PhoLip_ATPase_C	ATP8B3 ATP10B	3.43e-03	14	118	2	PF16212
Domain	PhoLip_ATPase_N	ATP8B3 ATP10B	3.43e-03	14	118	2	PF16209
Domain	Galectin_CRD	LGALS9B LGALS9	3.94e-03	15	118	2	IPR001079
Domain	Gal-bind_lectin	LGALS9B LGALS9	3.94e-03	15	118	2	PF00337
Domain	Gal-bind_lectin	LGALS9B LGALS9	3.94e-03	15	118	2	SM00908
Domain	GALECTIN	LGALS9B LGALS9	3.94e-03	15	118	2	PS51304
Domain	GLECT	LGALS9B LGALS9	3.94e-03	15	118	2	SM00276
Domain	Glycoside_hydrolase_SF	HEXA SLC3A2 GLB1	4.58e-03	53	118	3	IPR017853
Pubmed	Congenital hydrocephalus in genetically engineered mice.	KIF27 NME5 ULK4	8.83e-06	12	121	3	21746835
Pubmed	Characterization of the Functional Interplay between the BRD7 and BRD9 Homologues in mSWI/SNF Complexes.	BRD7 BRD9	1.20e-05	2	121	2	36484504
Pubmed	Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.	SPEG RYR2	1.20e-05	2	121	2	32683896
Pubmed	BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis.	BRD2 BRD7	1.20e-05	2	121	2	16786191
Pubmed	Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3).	ZCCHC8 ROS1	1.20e-05	2	121	2	27121553
Pubmed	Skeletal and cardiac ryanodine receptors bind to the Ca(2+)-sensor region of dihydropyridine receptor alpha(1C) subunit.	CACNA1C RYR2	1.20e-05	2	121	2	11576544
Pubmed	A natural allele of Nxf1 suppresses retrovirus insertional mutations.	CHRM1 SLC3A2 SLC22A8	1.45e-05	14	121	3	14517553
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SPEG ASH1L CHD7 JMJD1C DISP3 FAM135A	1.66e-05	153	121	6	10718198
Pubmed	Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.	LGALS9B LGALS9	3.59e-05	3	121	2	19776007
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9B LGALS9	3.59e-05	3	121	2	33316546
Pubmed	Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.	LGALS9B LGALS9	3.59e-05	3	121	2	9038233
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9B LGALS9	3.59e-05	3	121	2	28704475
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9B LGALS9	3.59e-05	3	121	2	23836896
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9B LGALS9	3.59e-05	3	121	2	7890611
Pubmed	Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.	LGALS9B LGALS9	3.59e-05	3	121	2	22341088
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9B LGALS9	3.59e-05	3	121	2	32380082
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9B LGALS9	3.59e-05	3	121	2	23667648
Pubmed	An NGS-based genotyping in LQTS; minor genes are no longer minor.	CACNA1C RYR2	3.59e-05	3	121	2	32681117
Pubmed	Deubiquitination and stabilization of T-bet by USP10.	TBX21 USP10	3.59e-05	3	121	2	24845384
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9B LGALS9	3.59e-05	3	121	2	28877989
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9B LGALS9	3.59e-05	3	121	2	19800850
Pubmed	The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.	LGALS9B LGALS9	3.59e-05	3	121	2	38987795
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9B LGALS9	3.59e-05	3	121	2	37105392
Pubmed	Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo).	INPP5D GAB1	3.59e-05	3	121	2	11402314
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9B LGALS9	3.59e-05	3	121	2	36479526
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9B LGALS9	3.59e-05	3	121	2	23242525
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9B LGALS9	3.59e-05	3	121	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9B LGALS9	3.59e-05	3	121	2	33923930
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9B LGALS9	3.59e-05	3	121	2	31969388
Pubmed	Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.	LGALS9B LGALS9	3.59e-05	3	121	2	35241678
Pubmed	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.	LGALS9B LGALS9	3.59e-05	3	121	2	22627368
Pubmed	Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.	LGALS9B LGALS9	3.59e-05	3	121	2	33153471
Pubmed	T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.	LGALS9B LGALS9	3.59e-05	3	121	2	22052881
Pubmed	Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.	LGALS9B LGALS9	3.59e-05	3	121	2	35643073
Pubmed	Galectin-9 functionally impairs natural killer cells in humans and mice.	LGALS9B LGALS9	3.59e-05	3	121	2	23408620
Pubmed	Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.	LGALS9B LGALS9	3.59e-05	3	121	2	29458010
Pubmed	Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.	LGALS9B LGALS9	3.59e-05	3	121	2	26582205
Pubmed	Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.	LGALS9B LGALS9	3.59e-05	3	121	2	9153289
Pubmed	Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.	LGALS9B LGALS9	3.59e-05	3	121	2	18974023
Pubmed	Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.	LGALS9B LGALS9	3.59e-05	3	121	2	23144904
Pubmed	Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.	LGALS9B LGALS9	3.59e-05	3	121	2	29651447
Pubmed	The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.	LGALS9B LGALS9	3.59e-05	3	121	2	21146220
Pubmed	Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.	LGALS9B LGALS9	3.59e-05	3	121	2	28990062
Pubmed	Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.	LGALS9B LGALS9	3.59e-05	3	121	2	18579572
Pubmed	TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.	RPS6KA2 TBX21	3.59e-05	3	121	2	37067748
Pubmed	Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.	LGALS9B LGALS9	3.59e-05	3	121	2	16990264
Pubmed	Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.	LGALS9B LGALS9	3.59e-05	3	121	2	18005988
Pubmed	Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.	LGALS9B LGALS9	3.59e-05	3	121	2	23585851
Pubmed	Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.	LGALS9B LGALS9	3.59e-05	3	121	2	24477688
Pubmed	A unique role for galectin-9 in angiogenesis and inflammatory arthritis.	LGALS9B LGALS9	3.59e-05	3	121	2	29433546
Pubmed	[Expression of BRD7-interacting proteins,BRD2 and BRD3, in nasopharyngeal carcinoma tissues].	BRD2 BRD7	3.59e-05	3	121	2	12600283
Pubmed	Alarmin function of galectin-9 in murine respiratory tularemia.	LGALS9B LGALS9	3.59e-05	3	121	2	25898318
Pubmed	Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.	LGALS9B LGALS9	3.59e-05	3	121	2	31937306
Pubmed	Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.	LGALS9B LGALS9	3.59e-05	3	121	2	21426359
Pubmed	Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.	LGALS9B LGALS9	3.59e-05	3	121	2	18282810
Pubmed	Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.	LGALS9B LGALS9	3.59e-05	3	121	2	24083426
Pubmed	Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.	LGALS9B LGALS9	3.59e-05	3	121	2	37279535
Pubmed	The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.	LGALS9B LGALS9	3.59e-05	3	121	2	25931247
Pubmed	Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes.	LGALS9B LGALS9	3.59e-05	3	121	2	17560833
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	CASC3 PDK1 ZCCHC8 BRINP1 RYR2 USP10 FRY AGO3 PCM1	3.62e-05	462	121	9	31138677
Pubmed	An approach based on a genome-wide association study reveals candidate loci for narcolepsy.	MPO CACNA1C GIT1 NR4A1 RAD1 GAB1	6.12e-05	193	121	6	20677014
Pubmed	SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.	LGALS9B LGALS9	7.17e-05	4	121	2	38686388
Pubmed	Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.	LGALS9B LGALS9	7.17e-05	4	121	2	22677125
Pubmed	Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.	LGALS9B LGALS9	7.17e-05	4	121	2	19234217
Pubmed	Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.	LGALS9B LGALS9	7.17e-05	4	121	2	35715604
Pubmed	Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.	LGALS9B LGALS9	7.17e-05	4	121	2	19017954
Pubmed	Galectin-9: A novel promoter of atherosclerosis progression.	LGALS9B LGALS9	7.17e-05	4	121	2	36459823
Pubmed	Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.	LGALS9B LGALS9	7.17e-05	4	121	2	29611821
Pubmed	Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2.	LGALS9B LGALS9	7.17e-05	4	121	2	33727589
Pubmed	The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.	LGALS9B LGALS9	7.17e-05	4	121	2	25578313
Pubmed	[Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].	LGALS9B LGALS9	7.17e-05	4	121	2	18826117
Pubmed	The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitors.	LGALS9B LGALS9	7.17e-05	4	121	2	38853593
Pubmed	Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias.	CACNA1C RYR2	7.17e-05	4	121	2	19383796
Pubmed	[Expression of Galectin-9 and Tim-3 in lungs of mice with asthma].	LGALS9B LGALS9	7.17e-05	4	121	2	21575348
Pubmed	Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.	LGALS9B LGALS9	7.17e-05	4	121	2	18346632
Pubmed	Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.	LGALS9B LGALS9	7.17e-05	4	121	2	19670381
Pubmed	Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.	LGALS9B LGALS9	7.17e-05	4	121	2	25450716
Pubmed	The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.	LGALS9B LGALS9	7.17e-05	4	121	2	16286920
Pubmed	Galectin-9 regulates the threshold of B cell activation and autoimmunity.	LGALS9B LGALS9	7.17e-05	4	121	2	34369876
Pubmed	Targeting the CD146/Galectin-9 axis protects the integrity of the blood-brain barrier in experimental cerebral malaria.	LGALS9B LGALS9	7.17e-05	4	121	2	33203936
Pubmed	Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation.	LGALS9B LGALS9	7.17e-05	4	121	2	33963043
Pubmed	Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.	LGALS9B LGALS9	7.17e-05	4	121	2	33107565
Pubmed	Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.	LGALS9B LGALS9	7.17e-05	4	121	2	30763585
Pubmed	Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.	LGALS9B LGALS9	7.17e-05	4	121	2	19362679
Pubmed	Intestinal Lamina Propria CD4+ T Cells Promote Bactericidal Activity of Macrophages via Galectin-9 and Tim-3 Interaction during Salmonella enterica Serovar Typhimurium Infection.	LGALS9B LGALS9	7.17e-05	4	121	2	29844236
Pubmed	Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.	LGALS9B LGALS9	7.17e-05	4	121	2	20463811
Pubmed	Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas.	LGALS9B LGALS9	7.17e-05	4	121	2	32855403
Pubmed	Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain.	LGALS9B LGALS9	7.17e-05	4	121	2	23657851
Pubmed	The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.	LGALS9B LGALS9	7.17e-05	4	121	2	24333756
Pubmed	Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.	LGALS9B LGALS9	7.17e-05	4	121	2	24958847
Pubmed	Galectin-9 binds IgM-BCR to regulate B cell signaling.	LGALS9B LGALS9	7.17e-05	4	121	2	30120235
Pubmed	Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge.	LGALS9B LGALS9	7.17e-05	4	121	2	11839756
Pubmed	Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.	LGALS9B LGALS9	7.17e-05	4	121	2	22021615
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GIT1 ZCCHC8 TATDN2 CHD7 CIC URGCP OTUD7B USP10 BRD2 UNG PCM1	8.58e-05	774	121	11	15302935
Pubmed	Loss of connectin novex-3 leads to heart dysfunction associated with impaired cardiomyocyte proliferation and abnormal nuclear mechanics.	CACNA1C RYR2 PCM1	8.93e-05	25	121	3	38877142
Pubmed	Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss.	LGALS9B LGALS9	1.19e-04	5	121	2	28951537
Pubmed	Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner.	LGALS9B LGALS9	1.19e-04	5	121	2	34847625
Pubmed	Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes.	ABCA6 ABCA5	1.19e-04	5	121	2	12532264
Pubmed	Astrocyte galectin-9 potentiates microglial TNF secretion.	LGALS9B LGALS9	1.19e-04	5	121	2	25158758
Pubmed	Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy.	LGALS9B LGALS9	1.19e-04	5	121	2	26278059
GeneFamily	Solute carriers	SLC6A16 SLC26A5 SLCO3A1 SLC3A2 SLC11A1 SLC22A8 SLCO2A1	1.35e-03	395	76	7	752
GeneFamily	ATP binding cassette subfamily A	ABCA6 ABCA5	1.54e-03	14	76	2	805
GeneFamily	Galectins	LGALS9B LGALS9	1.77e-03	15	76	2	629
GeneFamily	ATPase phospholipid transporting	ATP8B3 ATP10B	1.77e-03	15	76	2	1210
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 RGL3 ARX SLC26A5 SLCO3A1 HOXA6 EYS ASTN2	2.16e-08	171	120	8	dd37e1693a5cfc42e40992d504f92048a8038b52
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWA5B2 C2orf69 SLC26A5 RAD1 ASTN2 CREG2 HHIPL1	4.37e-07	172	120	7	de4961f4037c439d3e0ec706a257b0ec17f4d5be
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RGL3 HIVEP3 ABCA6 ABCA5 PKHD1 ASTN2 FAM135A	7.67e-07	187	120	7	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	HLA-DQA2 ZNF385A NR4A1 JMJD1C LGALS9 BRD2 TCF25	1.20e-06	200	120	7	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 RGL3 ARX BRINP1 EYS DMRTA2	3.72e-06	153	120	6	20786807bba3bcd70ce744f8b6454e064199ed9f
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C ABCA5 FRRS1L PKHD1 ROS1 LGR6	5.17e-06	162	120	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C RYR2 HIVEP3 ABCA6 MAMDC2 ASTN2	9.44e-06	180	120	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB CHRM1 RYR2 PKHD1 DISP3 ROS1	1.07e-05	184	120	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB CHRM1 RYR2 PKHD1 DISP3 ROS1	1.07e-05	184	120	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB CHRM1 RYR2 PKHD1 DISP3 ROS1	1.07e-05	184	120	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TTC16 SLC26A5 UGT2A1 PKHD1 DISP3	1.11e-05	108	120	5	d620f07243c2628494e689bbfabc14c453f4b1f4
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RGL3 FRY SLCO2A1 KCNJ15 PKHD1 ROS1	1.14e-05	186	120	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RGL3 NR4A1 FRY KCNJ15 PKHD1 ROS1	1.28e-05	190	120	6	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C SPEG RYR2 MAMDC2 ASTN2 LGR6	1.32e-05	191	120	6	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	CACNA1C CNNM2 SPEG RYR2 FRY LGR6	1.32e-05	191	120	6	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C RYR2 HIVEP3 ABCA6 MAMDC2 ULK4	1.40e-05	193	120	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 LGALS9B FRYL NR4A1 FRY DNAJC10	1.53e-05	196	120	6	c2d17630f7bfc9e727de55e093c17fddac61b61f
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 LGALS9B FRYL NR4A1 FRY DNAJC10	1.53e-05	196	120	6	54c30023d04e7265373647f56fc93885804938b0
ToppCell	AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ATP10B BRINP1 IGHG3 SLCO2A1 KCNJ15 ROS1	1.58e-05	197	120	6	5e0d222872a25bb9e9069d3dffda2844bb69874a
ToppCell	Control-PLT_4\|Control / Disease Group and Platelet Clusters	CNNM2 PDK1 JMJD1C RYR2 BRD7 GAB1	1.62e-05	198	120	6	387fd3037fd52e4d4c42de0588767e58af228b59
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ASH1L FRYL JMJD1C BRD7 TCF25 PCM1	1.72e-05	200	120	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	FRMD7 TBX21 CCDC168 MUC17	3.24e-05	67	120	4	e53dfc288c943656a0b064afe593ea2101d75437
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	FRMD7 TBX21 CCDC168 MUC17	3.24e-05	67	120	4	1841cee311a4b1b802c9e872793435afb730592f
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	C4orf54 WNT16 PKHD1 HHIPL1	4.07e-05	71	120	4	b0dbb059a7d05f825da608879b23aeebd6e9e61f
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	C4orf54 WNT16 PKHD1 HHIPL1	4.07e-05	71	120	4	149504ce72da0730074ea436fc2034ce8cb585d5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF27 FAM83C PKHD1 ULK4 ASTN2	4.30e-05	143	120	5	7a7a9829ba63468c9745904d9e993590051207ab
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWA5B2 GPR85 DISP3 ROS1 PADI6	4.44e-05	144	120	5	e9d62f202f0fa8747961036ef0eafed91fe8a42f
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	CDHR3 SLCO3A1 DISP3 CREG2 SP7	5.22e-05	149	120	5	649eb3441fa859591ea85f1ed5fcf08af272a32b
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-DQA2 ZNF385A WDFY4 LGALS9 RMI1	5.22e-05	149	120	5	71d72a6e7b128ee96161e08f6a0d77be925e73a1
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	CACNA1C RYR2 ABCA6 MAMDC2 HHIPL1	7.11e-05	159	120	5	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 RGL3 ARX DMRTA2 ROS1	7.32e-05	160	120	5	6c89a2e4189e4f2b6b09b66c6aae6653785ab2f8
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ST6GALNAC1 LGALS9B CHD7 FAM222A UGT2A1	7.54e-05	161	120	5	9cfbbcd38ec2e75376bbc26001964b6991ad0e21
ToppCell	normal_Lymph_Node-B_lymphocytes-Undetermined\|normal_Lymph_Node / Location, Cell class and cell subclass	CYP2A6 HLA-DQA2 INPP5D CHD7 EFHC1	7.77e-05	162	120	5	91ac35ae7fde411cd6a44e715a33dac62419cab8
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C CNNM2 SPEG FRY LGR6	7.99e-05	163	120	5	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	Adult-Mesenchymal-chondrocyte-D231\|Adult / Lineage, Cell type, age group and donor	CACNA1C RYR2 ABCA6 MAMDC2 HHIPL1	8.23e-05	164	120	5	2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T\|bone_marrow / Manually curated celltypes from each tissue	MPO GPR85 PGD HOXA6 ALAS1	8.71e-05	166	120	5	20f248d95c86eb52a1efe9abe73123fbe4206caf
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Pvalb_(Non-anterior_nuclei)\|Thalamus / BrainAtlas - Mouse McCarroll V32	FRYL FAM83C NLRP10 SLCO2A1	9.03e-05	87	120	4	fd0df79b02f96463a6bad90dcd019c59c8e3eb0e
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 TTC16 CDHR3 EFHC1 NME5	9.22e-05	168	120	5	fa7c0303918cea04e3f4c4f3cb079be19004d214
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 ARX EYS ABCA6 ABCA5	9.22e-05	168	120	5	0f736d58cb0ff042fa3ce58e36bde37b6976f8fc
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF27 TTC16 CDHR3 EFHC1 NME5	9.22e-05	168	120	5	7edcab103c69e928d5c19a0d218ffb3ae32f9e70
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWA5B2 TTC16 CDHR3 SLC26A5 EFHC1	9.48e-05	169	120	5	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG TMEM175 C4orf54 RYR2 LGR6	9.74e-05	170	120	5	cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 RGL3 ARX EYS PKHD1	9.74e-05	170	120	5	985c2d5962100fab0d95bee39f382ccbe799331e
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG TMEM175 C4orf54 RYR2 LGR6	9.74e-05	170	120	5	da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ST6GALNAC1 USP10 FRY KCNJ15 ABHD13	9.74e-05	170	120	5	51dbfa07daf6f972b566f3f6abe7f46e080ec01c
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 ARX SLC26A5 SLCO3A1 DMRTA2	1.00e-04	171	120	5	c54dcad75fc378da1943009d7dd872b39ea337c0
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C SPEG RYR2 MAMDC2 LGR6	1.00e-04	171	120	5	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C SPEG NR4A1 RYR2 LGR6	1.03e-04	172	120	5	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 RGL3 ARX EYS ABCA5	1.03e-04	172	120	5	2651dece87c3e3d2d6370f5274ebae357474b825
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDK1 INPP5D ARX WDFY4 IGHG3	1.06e-04	173	120	5	62ba49c1c16760a8c6cde0cc44e068f94386946a
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	KIF27 TTC16 CDHR3 NME5 ULK4	1.09e-04	174	120	5	f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C RPS6KA2 FRYL ULK4 FAM135A	1.09e-04	174	120	5	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	IIF-Lymphocyte-B-B_intermediate\|IIF / Disease, Lineage and Cell Type	CYP2A6 HLA-DQA2 WDFY4 IGHG3 WNT16	1.12e-04	175	120	5	327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C SPEG NR4A1 FRY LGR6	1.12e-04	175	120	5	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	KIF27 TTC16 CDHR3 NME5 ULK4	1.12e-04	175	120	5	c01a15b2084da4a18f8ff3623f44eb9dfe499f10
ToppCell	Control-B_cells\|Control / group, cell type (main and fine annotations)	PDK1 INPP5D WDFY4 IGHG3 GAB1	1.15e-04	176	120	5	9125caa27bf790f6b1b960a86c09b4bcb1b58641
ToppCell	COVID-19-B_cells-Activated_B_cells\|COVID-19 / group, cell type (main and fine annotations)	INPP5D CHD7 WDFY4 MGAT5 WNT16	1.18e-04	177	120	5	653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell	COVID-19-kidney-PCT-S1/S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDHR3 SLC22A8 KCNJ15 PKHD1 ASTN2	1.21e-04	178	120	5	23a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C RPS6KA2 ABCA5 ULK4 FAM135A	1.21e-04	178	120	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 CDHR3 FAM222A DISP3 ROS1	1.24e-04	179	120	5	f2e8fc975c30992611630197b79daaeef7c4211d
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 RGL3 SLC26A5 SLC22A8 FAM222A	1.24e-04	179	120	5	06f92c884189197c86793191c05f65e34925c097
ToppCell	COVID-19-kidney-Stressed_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDHR3 SLC22A8 KCNJ15 PKHD1 ASTN2	1.31e-04	181	120	5	6980ea624151da32b7f537f263e40fcb87a02e81
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	INPP5D RPS6KA2 RYR2 LGALS9 SLCO2A1	1.34e-04	182	120	5	7af3b2029b7f55b923d5a4b764d4292f4ea48599
ToppCell	E18.5-samps-Endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	INPP5D RPS6KA2 RYR2 LGALS9 SLCO2A1	1.34e-04	182	120	5	e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARX SLCO3A1 EYS ABCA5 FRRS1L	1.38e-04	183	120	5	d23018193b9c0806e0d1a9ac15e6392eb8e96aaf
ToppCell	3'_v3-blood-Lymphocytic_B-Memory_B_cells\|blood / Manually curated celltypes from each tissue	HLA-DQA2 WDFY4 ABCA6 IGHG3 WNT16	1.38e-04	183	120	5	e3a418b745d7f040adf47be9e1043b945cae47ed
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDK1 INPP5D WDFY4 MGAT5 IGHG3	1.41e-04	184	120	5	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDK1 INPP5D WDFY4 MGAT5 IGHG3	1.41e-04	184	120	5	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDK1 INPP5D WDFY4 IGHG3 WNT16	1.41e-04	184	120	5	f81209e6bc01a0140f4487aa8b22eb02fbf0c39c
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HLA-DQA2 RGL3 FRY KCNJ15 PKHD1	1.41e-04	184	120	5	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JMJD1C RYR2 SLC11A1 PKHD1 TCF25	1.48e-04	186	120	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CNNM2 SPEG RYR2 LGR6	1.48e-04	186	120	5	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CNNM2 SPEG RYR2 LGR6	1.48e-04	186	120	5	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	severe_influenza-B_intermediate\|severe_influenza / disease group, cell group and cell class (v2)	HLA-DQA2 CHD7 WDFY4 IGHG3 WNT16	1.52e-04	187	120	5	d6db8595aa72fdabc4a056ba6ce09876868a66d5
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	CACNA1C RYR2 ABCA6 MAMDC2 ULK4	1.52e-04	187	120	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 TBX21 GPR85 KCNJ15 LGR6	1.52e-04	187	120	5	cfdc1585c80d2bb475d9145395fb50a88c53f838
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 TBX21 GPR85 KCNJ15 LGR6	1.52e-04	187	120	5	b426a67b5669019115b58295ce7d304beeb75825
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RGL3 ABCA6 ABCA5 PKHD1 GAB1	1.52e-04	187	120	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	COVID-19-kidney-Mito-rich_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	CDHR3 SLC22A8 KCNJ15 PKHD1 ASTN2	1.52e-04	187	120	5	738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	INPP5D CHD7 NR4A1 WDFY4 MGAT5	1.56e-04	188	120	5	d1bc1316bbb8cfc39acc70f8680b14d19f536997
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CNNM2 SPEG RYR2 LGR6	1.60e-04	189	120	5	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CNNM2 SPEG RYR2 LGR6	1.60e-04	189	120	5	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO3A1 NR4A1 FRY SLCO2A1 WNT16	1.60e-04	189	120	5	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RGL3 ABCA6 ABCA5 PKHD1 GAB1	1.60e-04	189	120	5	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	SLCO3A1 NR4A1 JMJD1C FRY MGAT5	1.64e-04	190	120	5	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	GPR85 RYR2 FRY EFHC1 FRRS1L	1.64e-04	190	120	5	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CNNM2 SPEG RYR2 LGR6	1.64e-04	190	120	5	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2A6 CDHR3 ATP10B EFHC1 UGT2A1	1.64e-04	190	120	5	2fdc024d3d673a0134b74b4c5a63afe924995730
ToppCell	Control-Lymphoid_B-B_intermediate\|Control / Disease group, lineage and cell class	CHD7 WDFY4 ABCA6 IGHG3 WNT16	1.68e-04	191	120	5	0082181dbc39c7c4fd3aa34c3ed61439548e844b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RGL3 NR4A1 KCNJ15 PKHD1 ROS1	1.68e-04	191	120	5	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CNNM2 SPEG RYR2 LGR6	1.68e-04	191	120	5	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RGL3 SLCO3A1 KCNJ15 PKHD1 ROS1	1.68e-04	191	120	5	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	tumor_Lung-Myeloid_cells-Alveolar_Mac\|tumor_Lung / Location, Cell class and cell subclass	HLA-DQA2 PGD LGALS9 SLC11A1 ALAS1	1.72e-04	192	120	5	44eda67501e69799c5981be602c143d12f5f222f
ToppCell	healthy_donor-Lymphocytic-B_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-DQA2 CHD7 WDFY4 DNAJC10 IGHG3	1.72e-04	192	120	5	7d9e5772b6e531b50ed4e4d6304ef11235f27f37
ToppCell	Control-B_intermediate-10\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TBX21 SLC11A1 ABCA6 IGHG3 WNT16	1.72e-04	192	120	5	224bd958369ba8fa0d7be2126f7dc61c9f6ac19d
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C2orf69 CHD7 EFHC1 MAMDC2 WNT16	1.72e-04	192	120	5	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	healthy_donor-Lymphocytic-B_cell-\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-DQA2 CHD7 WDFY4 DNAJC10 IGHG3	1.72e-04	192	120	5	975312f9d6cede4d4f5b737e481e5c73accc8c50
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQA2 CHD7 WDFY4 IGHG3 WNT16	1.76e-04	193	120	5	7cc10e8b51091869d46e462f3214999e7b5348b1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RPS6KA2 ARX EYS WNT16 ASTN2	1.76e-04	193	120	5	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HEXA HLA-DQA2 PGD SLC11A1 ALAS1	1.76e-04	193	120	5	2653f83bc0289abdb4270c176ebdc24242600f9a
Disease	juvenile myoclonic epilepsy (is_implicated_in)	EFHC1 BRD2	1.51e-05	2	115	2	DOID:4890 (is_implicated_in)
Disease	Colorectal Carcinoma	MPO CYP2A6 APOB BRINP1 HIVEP3 ABCA6 ABCA5 SLCO2A1 WNT16 PKHD1 UNG LGR6	1.98e-05	702	115	12	C0009402
Disease	disease free survival	CCDC168 CHRM1 SLC3A2	4.51e-05	18	115	3	EFO_0000409
Disease	hydrocephalus (implicated_via_orthology)	KIF27 NME5 ULK4	5.34e-05	19	115	3	DOID:10908 (implicated_via_orthology)
Disease	Involutional paraphrenia	MPO CACNA1C NR4A1	1.25e-04	25	115	3	C1571983
Disease	Psychosis, Involutional	MPO CACNA1C NR4A1	1.25e-04	25	115	3	C1571984
Disease	Involutional Depression	MPO CACNA1C NR4A1	1.25e-04	25	115	3	C0011574
Disease	retinitis pigmentosa	EYS DNAJC10	2.24e-04	6	115	2	MONDO_0019200
Disease	stromal cell-derived factor 1 measurement	ABCA6 ABCA5	3.12e-04	7	115	2	EFO_0020756
Disease	sodium measurement	CYP2A6 BRINP1 JMJD1C PKHD1	7.19e-04	103	115	4	EFO_0009282
Disease	Gastric Adenocarcinoma	SPEG BRD2 ROS1	7.26e-04	45	115	3	C0278701
Disease	cholesterol to total lipids in large VLDL percentage	APOB JMJD1C ABCA6	7.26e-04	45	115	3	EFO_0022236
Disease	Colorectal Neoplasms	CYP2A6 ABCA6 ABCA5 SLCO2A1 UNG LGR6	7.76e-04	277	115	6	C0009404
Disease	Occupational Diseases	MPO CARD8	8.09e-04	11	115	2	C0028797
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	CYP2A6 APOB ABCA6 ALAS1	8.30e-04	107	115	4	EFO_0004614, EFO_0004615
Disease	cholesteryl esters to total lipids in small VLDL percentage	APOB JMJD1C ABCA6	9.32e-04	49	115	3	EFO_0022256
Disease	triglycerides to total lipids in medium LDL percentage	APOB JMJD1C ABCA6	9.89e-04	50	115	3	EFO_0022334
Disease	free cholesterol in large LDL measurement	APOB JMJD1C ABCA6	1.05e-03	51	115	3	EFO_0022176
Disease	generalised epilepsy	RYR2 PADI6 ARMH3	1.11e-03	52	115	3	EFO_0005917
Disease	triglycerides to total lipids in very large VLDL percentage	APOB JMJD1C ABCA6	1.17e-03	53	115	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	APOB JMJD1C ABCA6	1.17e-03	53	115	3	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	APOB JMJD1C ABCA6	1.24e-03	54	115	3	EFO_0022244
Disease	cholesteryl esters to total lipids in large VLDL percentage	APOB JMJD1C ABCA6	1.38e-03	56	115	3	EFO_0022250
Disease	angina pectoris	CNNM2 APOB BRINP1 FAM222A	1.48e-03	125	115	4	EFO_0003913
Disease	cholesterol in IDL measurement	APOB JMJD1C ABCA6	1.52e-03	58	115	3	EFO_0021899
Disease	N-acetylmethionine measurement	SLCO3A1 ABHD14B	1.53e-03	15	115	2	EFO_0021427
Disease	triglycerides to total lipids in small LDL percentage	APOB JMJD1C ABCA6	1.60e-03	59	115	3	EFO_0022337
Disease	free cholesterol to total lipids in very large VLDL percentage	APOB JMJD1C ABCA6	1.60e-03	59	115	3	EFO_0022289
Disease	eye morphology measurement	BRINP1 FRY ULK4 ASTN2 PCM1	1.67e-03	218	115	5	EFO_0007858
Disease	total lipids in IDL	APOB JMJD1C ABCA6	1.68e-03	60	115	3	EFO_0022161
Disease	Brain Ischemia	MPO CHRM1 ADD3	1.68e-03	60	115	3	C0007786
Disease	Cerebral Ischemia	MPO CHRM1 ADD3	1.68e-03	60	115	3	C0917798
Disease	free cholesterol in IDL measurement	APOB JMJD1C ABCA6	1.76e-03	61	115	3	EFO_0022181
Disease	triglycerides to total lipids in IDL percentage	APOB JMJD1C ABCA6	1.93e-03	63	115	3	EFO_0022329
Disease	gestational age	FRMD7 HIVEP3 EYS MGAT5	2.12e-03	138	115	4	EFO_0005112
Disease	Profound Mental Retardation	HEXA ZCCHC8 CIC FRY	2.18e-03	139	115	4	C0020796
Disease	Mental Retardation, Psychosocial	HEXA ZCCHC8 CIC FRY	2.18e-03	139	115	4	C0025363
Disease	Mental deficiency	HEXA ZCCHC8 CIC FRY	2.18e-03	139	115	4	C0917816
Disease	caudal middle frontal gyrus volume measurement	FRY ASTN2	2.21e-03	18	115	2	EFO_0010290
Disease	ascending aortic diameter	JMJD1C RYR2 HIVEP3 ULK4	2.23e-03	140	115	4	EFO_0021787
Disease	bipolar I disorder	CACNA1C RPS6KA2 BRINP1 ASTN2	2.29e-03	141	115	4	EFO_0009963
Disease	Cannabis use, age at onset	RYR2 RMI1	2.47e-03	19	115	2	EFO_0004847, EFO_0007585
Disease	leukemia (implicated_via_orthology)	ASH1L HOXA6	2.47e-03	19	115	2	DOID:1240 (implicated_via_orthology)
Disease	triglycerides to total lipids in very small VLDL percentage	APOB JMJD1C ABCA6	2.51e-03	69	115	3	EFO_0022341
Disease	Manic Disorder	CACNA1C RPS6KA2 ADD3	2.72e-03	71	115	3	C0024713
Disease	asthma	CDHR3 TBX21 ATP10B JMJD1C USP10 MGAT5 BRD2 GLB1 GAB1	2.74e-03	751	115	9	MONDO_0004979
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	APOB JMJD1C RMI1 ABCA6	2.87e-03	150	115	4	EFO_0004611, EFO_0020947
Disease	fumarate measurement	RPS6KA2 EYS	3.01e-03	21	115	2	EFO_0010480
Disease	docosahexaenoic acid to total fatty acids percentage	APOB JMJD1C	3.01e-03	21	115	2	EFO_0022262
Disease	pulse pressure measurement	PAQR9 CNNM2 TTC16 RGL3 FRYL HIVEP3 UGT2A1 OR4C46 ULK4 DMRTA2 HHIPL1 ARMH3 PCM1	3.04e-03	1392	115	13	EFO_0005763
Disease	free cholesterol to total lipids in large LDL percentage	APOB JMJD1C ABCA6	3.06e-03	74	115	3	EFO_0022280
Disease	FEV/FEC ratio	SPEG BRINP1 JMJD1C ADD3 OTUD7B HIVEP3 EFHC1 MGAT5 WNT16 ULK4 ASTN2 HHIPL1	3.06e-03	1228	115	12	EFO_0004713
Disease	serum gamma-glutamyl transferase measurement	CYP2A6 ASH1L JMJD1C OMG RYR2 RMI1 EYS PKHD1 ASTN2 DMRTA2	3.09e-03	914	115	10	EFO_0004532
Disease	response to bronchodilator, FEV/FEC ratio	MPO CACNA1C CYP2A6 SLCO3A1 BRINP1 EFHC1 MGAT5 PKHD1 ULK4	3.12e-03	766	115	9	EFO_0004713, GO_0097366
Disease	free cholesterol to total lipids in small VLDL percentage	APOB JMJD1C ABCA6	3.18e-03	75	115	3	EFO_0022287
Disease	unipolar depression, bipolar disorder	CACNA1C CNNM2 BRINP1 ASTN2	3.30e-03	156	115	4	EFO_0003761, MONDO_0004985
Disease	Attention Deficit Disorder	GIT1 CIC	3.31e-03	22	115	2	C0041671
Disease	Minimal Brain Dysfunction	GIT1 CIC	3.31e-03	22	115	2	C1321905
Disease	atrial fibrillation	CDHR3 JMJD1C NME5 ASTN2 ARMH3 PCM1	3.39e-03	371	115	6	EFO_0000275
Disease	asparaginase hypersensitivity	CDHR3 SLCO3A1 LGR6	3.42e-03	77	115	3	EFO_0004881
Disease	peak expiratory flow	PGD ZCCHC14 FRY EYS EFHC1 GLCE ASTN2	3.43e-03	498	115	7	EFO_0009718
Disease	Manic	CACNA1C RPS6KA2 ADD3	3.55e-03	78	115	3	C0338831
Disease	very low density lipoprotein cholesterol measurement	CYP2A6 APOB JMJD1C MGAT5 ABCA6	3.57e-03	260	115	5	EFO_0008317
Disease	Immunologic Deficiency Syndromes	CACNA1C CHD7	3.61e-03	23	115	2	C0021051
Disease	Depression, Bipolar	CACNA1C RPS6KA2 ADD3	3.68e-03	79	115	3	C0005587
Disease	body weight	CACNA1C C2orf69 CNNM2 BRINP1 CHD7 OTUD7B EYS FRRS1L KCNJ15 ULK4 ASTN2 PCM1	3.79e-03	1261	115	12	EFO_0004338

Protein segments in the cluster

Peptide	Gene	Start	Entry
MIGQKTLYSFFSPSP	UNG	1	P13051
EPAPTLGLFSNYSTM	ZNF385A	36	Q96PM9
SYELRFFPDMIPVSS	ABCA5	136	Q8WWZ7
ASTLFSFFPMRYLPL	ABHD13	226	Q7L211
VPSFPSMAYSAAAGL	FAM222A	236	Q5U5X8
MHSLSFPLSSTGFYP	ASH1L	1366	Q9NR48
PSSLMTYFFPTERGG	DISP3	336	Q9P2K9
MSFYPPSLNDASFTL	C2orf69	246	Q8N8R5
VYPMLGSVLRDPSFF	CYP2A6	391	P11509
LDPMFFVYVNPFSGS	BRINP1	556	O60477
FSFPVTDFIAPGYSM	BRD7	156	Q9NPI1
FAFPVTDAIAPGYSM	BRD9	161	Q9H8M2
DYIMANSFSGFSSPP	ADD3	96	Q9UEY8
FPDPSGDSYTMIATF	ABCA6	386	Q8N139
AGIPMPCFTTALSFY	PGD	416	P52209
FNMFITYGDTFLPTP	ARMH3	531	Q5T2E6
PTTPSSFVLNGFMYS	GLCE	501	O94923
AFSMYEPGSALKPFG	GIT1	506	Q9Y2X7
PTTFPFLYADLSVMS	ATP8B3	1171	O60423
PSMKYTPVGRSFFSA	AGO3	171	Q9H9G7
RGAMFPTFTSPEDLY	C7orf31	156	Q8N865
NPFLLSTMAPGLFYP	CHD7	2891	Q9P2D1
AFMAPYSTAGLVPTL	DMRTA2	481	Q96SC8
NSTGIPFFYMTAKDP	CREG2	166	Q8IUH2
PLPYDATSSTIFMFC	ASTN2	721	O75129
SFLPSALGGFYMFLT	ATP10B	356	O94823
MSPDKPYFRLSTFGN	RAD1	181	O60671
VDFYARFSPSPLSMK	PDK1	46	Q15118
SPLTTAPMAGCLSFY	MAMDC2	236	Q7Z304
APTALPSFSTFMDGY	NR4A1	46	P22736
SLSGMYSLPFLTAPG	ABHD14B	111	Q96IU4
MAFSTGYPGDFTIPR	OTUD7B	686	Q6GQQ9
DEFPMKYSLSPGIGY	PADI6	386	Q6TGC4
LPMFSKFISFDPQSA	HLA-DQA2	71	P01906
MSSYFVNPTFPGSLP	HOXA6	1	P31267
MPIRTSAATLGFFFP	EYS	1371	Q5T1H1
FYTMFPHTPDNSFLG	MGAT5	411	Q09328
FFLPVMSSEPSYSFL	ERVS71-1	31	P61550
ELYFMSTGEPSATAP	HHIPL1	551	Q96JK4
SYAAGFIFTTSLPPM	ALAS1	466	P13196
FLSFASMLGLFPVTP	LGR6	791	Q9HBX8
STDIFMAYVSTFLPP	NLRP10	381	Q86W26
NYVPMTPGTFDFSSF	GAB1	471	Q13480
IAFAPVYSMGAPSSK	JMJD1C	2086	Q15652
MAFSGSQAPYLSPAV	LGALS9B	1	Q3B8N2
MAFSGSQAPYLSPAV	LGALS9	1	O00182
SSSFPFIYMDPVFNT	FRMD7	411	Q6ZUT3
FYMGNFSIPSGIPDL	GLB1	551	P16278
FMYSEVPLLASSVPY	FAM135A	1221	Q9P2D6
TSPPMYSLDRIFAGF	KIF27	606	Q86VH2
FMLPSYSFPSGTPNL	PER2	906	O15055
YMAFPKPFESSSSIG	PCM1	1176	Q15154
ETLGSPMYFFLAGLS	OR4A47	51	Q6IF82
PSLGSPMYLSLAYLS	OR4C46	51	A6NHA9
VDGFTFTPITMTFPF	OR2T4	186	Q8NH00
PMYFFLGNLSLPDVG	OR3A4P	61	P47883
GSASPMELLSYFKQP	MPO	91	P05164
AGPFSIMFTPLDRYS	FRYL	1081	O94915
FFPNLTAYMSSGPLV	NME5	66	P56597
RYAFFMPTLPSLVSF	INTS2	1096	Q9H0H0
SSSESPFLILPMTFY	KCNJ15	241	Q99712
FTGPGFLMSIAFLDP	SLC11A1	61	P49279
SFMPAFLATYRTFVP	RGL3	91	Q3MIN7
PAAPTFSGTVGYMLL	PAQR9	341	Q6ZVX9
GTIAMGPFFLTLLSY	OR12D1	196	P0DN82
SPFTIEMSAFGYVFP	APOB	3261	P04114
GYVFPKAVSMPSFSI	APOB	3271	P04114
FVYPFGATLSVMKPA	IFT52	166	Q9Y366
LLAPTYFSAPGVMNF	CASC3	616	O15234
AVPMPEASAFFIFSS	CACNA1C	871	Q13936
VTSGTYFPMASDIDP	FAM83C	111	Q9BQN1
SYFLISPPKSFRMSA	CDHR3	171	Q6ZTQ4
DIFMPSAAYQTFSSP	FRRS1L	261	Q9P0K9
PFYAVLESPSFSLMG	CARD8	286	Q9Y2G2
PIITFGTAMAAFYLP	CHRM1	186	P11229
MLFTLPGTPVFSYGD	SLC3A2	456	P08195
FISPAFGRLFSTMAP	ARX	476	Q96QS3
SYFLATDMISIFEPP	EFHC1	441	Q5JVL4
AMAFPPVLDVGTYSF	GPR85	151	P60893
YNTTPPMLDSDGSFF	IGHG3	321	P01860
AGPFSIMFTPLDRYS	FRY	1131	Q5TBA9
ATFLGPLDFFMPVLS	CCDC168	2356	Q8NDH2
YPSLFIFRSGMAPVK	DNAJC10	201	Q8IXB1
TFTEAPYFMASGQSP	C4orf54	1721	D6RIA3
GAAFSPTFPIYMVFR	SLC22A8	166	Q8TCC7
QLTSGYKPAPMDLSF	RYR2	971	Q92736
DIIASPSLGSPMYFF	OR4A5	46	Q8NH83
PSLGSPMYFFLACLS	OR4A5	51	Q8NH83
MAFVSTAPLPSFEAY	MUC17	161	Q685J3
FPYESFTFPELMRKG	HEXA	211	P06865
AAAAAAATVYPTFPM	SKOR1	476	P84550
FLSFVEAMSFLPPSV	SLC6A16	481	Q9GZN6
PLLKYFPNMSVGFTA	TATDN2	666	Q93075
FFSSLLMFGFPQSLP	SLCO3A1	276	Q9UIG8
SIAMDLYSPPFVYLS	RMI1	481	Q9H9A7
FAMLAAVPPIFGLYS	SLC26A5	101	P58743
MFENPLYGSLSSFPK	INPP5D	1016	Q92835
FAPPFGFMELNYSLV	ST6GALNAC1	321	Q9NSC7
SMFPSFSGLFISPKL	PKHD1	1856	P08F94
MYPTPSGFTSSLFTV	OMG	266	P23515
PSLLYEGFESPTMAS	BRD2	36	P25440
PFPSATAGSMTYSLV	CIC	1151	Q96RK0
TFMRNLPITPGYSGF	C10orf82	6	Q8WW14
SYYGVMALTASPVPL	CNNM2	711	Q9H8M5
FFMGCSTPTVAEVYP	SLCO2A1	416	Q92959
PPMAAVSLAYSEAIF	URGCP	886	Q8TCY9
PDMSKFATGITPFEF	ZCCHC8	661	Q6NZY4
MTIFTSPASPSKEFY	ZDHHC20	71	Q5W0Z9
TFLPYTFSLMVTFPD	TMEM175	121	Q9BSA9
TYIMLSGRSPFYEPD	SPEG	3151	Q15772
ASKTMGDAYPAPFTS	SP7	56	Q8TDD2
MPYPTSSALSSGFFL	HIVEP3	1226	Q5T1R4
GPFLSMDPSAFVDVY	WDFY4	1201	Q6ZS81
APMGASPLFGYELSS	WNT16	101	Q9UBV4
AYSSVMQPFPDKAFL	ROS1	1431	P08922
TFPFLPFSPMCSSGY	ZCCHC14	821	Q8WYQ9
PAPYTFSFEMLVTGP	VWA5B2	211	Q8N398
MALHSPQYIFGDFSP	USP10	1	Q14694
NPLDPSLFLFRGTMY	TTC16	281	Q8NEE8
PFMYSLRFSPASTVE	UGT2A1	166	P0DTE4
MGFDPLPPSDTIYSY	TCF25	581	Q9BQ70
MFPFLSFTVAGLEPT	TBX21	166	Q9UL17
EMFSGKPPFFSESIS	ULK4	211	Q96C45
LYTMLAGFTPFANGP	RPS6KA2	601	Q15349
PFALSKSSMYTVGAP	NDC80	161	O14777